United States News All stories

CIMG (NASDAQ:IMG), a business group specializing in digital health and technology-driven sales development, announced its financial results for the first quarter ended December 31, 2025.

Cintas (NASDAQ:CTAS), the premier provider of corporate identity uniforms and facility services, reported financial results for its fiscal third quarter ended February 28, 2026.

Energous (NASDAQ:WATT), a leading developer of RF-based wireless power networks, announced its financial results for the fiscal year ended December 31, 2025.

Maze Therapeutics (NASDAQ:MAZE), a clinical-stage biopharmaceutical company applying genetic insights to the development of precision medicines, reported its fourth-quarter and full-year 2025 financial results on Wednesday, March 25, 2026.

Paychex (NASDAQ:PAYX), a prominent provider of integrated human capital management (HCM) solutions, announced its financial results for the third quarter ended February 28, 2026.

BeyondSpring (NASDAQ:BYSI), a clinical-stage biopharmaceutical company focused on transformative cancer therapies, today announced its financial results for the fiscal year ended December 31, 2025.

ProMIS Neurosciences (NASDAQ:PMN), a biotechnology company developing antibody therapeutics for neurodegenerative diseases, reported its full-year 2025 financial results and provided a comprehensive corporate update on March 25, 2026.

QT Imaging Holdings (NASDAQ:QTI), a medical technology company specializing in radiation-free breast health management, announced its financial results for the fourth quarter and full year ended December 31, 2025.

Kingsoft Cloud Holdings (NASDAQ:KC), an independent cloud service provider in China, announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on March 25, 2026.

Winnebago Industries (NYSE:WGO), a North American manufacturer of outdoor lifestyle products, announced its financial results for the second quarter of fiscal 2026 on Wednesday.

KalVista Pharmaceuticals (NASDAQ:KALV) today reported financial results for the abbreviated fiscal period ended December 31, 2025, marking the company’s formal transition from a clinical-stage developer to a commercial-stage biopharmaceutical entity.

EDAP TMS (NASDAQ:EDAP), a global leader in robotic energy-based therapies, announced record financial results for the fourth quarter and full year ended December 31, 2025.

Lockheed Martin (NYSE:LMT) and the U.S. Department of War (DoW) announced a landmark framework agreement on March 25, 2026, to dramatically accelerate the manufacturing of Precision Strike Missiles (PrSM).

Local Bounti (NYSE:LOCL), a leader in controlled environment agriculture (CEA), announced its financial results for the fourth quarter and full year ended December 31, 2025.

Kiora Pharmaceuticals (NASDAQ:KPRX) released its fourth-quarter and full-year 2025 financial results on Wednesday, detailing a streamlined balance sheet and steady clinical momentum for its pipeline of retinal disease treatments.

Honeywell Aerospace (NASDAQ:HON) entered into a landmark supplier framework agreement with the U.S. Department of War on March 25, 2026, marking a significant escalation in the company’s defense manufacturing footprint.

Cognyte Software (NASDAQ:CGNT), a global provider of investigative analytics software, announced its financial results for the fourth quarter and full fiscal year ended January 31, 2026.

Chewy (NYSE:CHWY), the leading online destination for pet products and services, released its financial results for the fiscal fourth quarter and full year 2025, ended February 1, 2026.

KNOT Offshore Partners (NYSE:KNOP) announced its financial results for the fourth quarter ended December 31, 2025, detailing a period of high operational uptime and strategic refinancing despite a significant non-cash accounting charge.

Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, has entered into a definitive agreement to acquire clinical-stage oncology firm Terns Pharmaceuticals (NASDAQ:TERN) for approximately $6.7 billion in equity value.

ADMA Biologics (NASDAQ:ADMA), a U.S.-based commercial biopharmaceutical company specializing in the manufacture and marketing of specialty biologics, issued a formal statement on Wednesday addressing a critical report published on March 24, 2026, by Culper Research.

17 Education & Technology Group (NASDAQ:YQ), a leading provider of educational technology in China, announced its unaudited financial results for the fourth quarter and full fiscal year ended December 31, 2025, on Wednesday.

Energy Fuels (NYSE:UUUU) has successfully produced its first kilogram of terbium oxide at 99.9% purity, marking what the company describes as the first primary production of the heavy rare earth material in the United States in decades.

Baozun (NASDAQ:BZUN), a leading brand e-commerce service partner in China, announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on March 25, 2026.